{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T09:17:01Z","timestamp":1775985421531,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Hellenic Pasteur Institute"},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["14910"],"award-info":[{"award-number":["14910"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["158763"],"award-info":[{"award-number":["158763"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jneuroim.2016.12.011","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T15:02:52Z","timestamp":1482332572000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains"],"prefix":"10.1016","volume":"303","author":[{"given":"Konstantinos","family":"Lazaridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Baltatzidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Koutroumpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Karandreas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.12.011_bb0005","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2015.09.005","article-title":"Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells","volume":"67","author":"Aricha","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0015","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.revmed.2013.09.012","article-title":"Myasthenia gravis and autoantibodies: pathophysiology of the different subtypes","volume":"35","author":"Berrih-Aknin","year":"2014","journal-title":"Rev. Med. Interne."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0025","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbapap.2008.04.023","article-title":"Mutant forms of the extracellular domain of the human acetylcholine receptor gamma-subunit with improved solubility and enhanced antigenicity. The importance of the cys-loop","volume":"1784","author":"Bitzopoulou","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-5728(03)00209-1","article-title":"Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis","volume":"140","author":"Feferman","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2014.06.003","article-title":"Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches","volume":"54","author":"Fuchs","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0040","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.4049\/jimmunol.140.6.1830","article-title":"Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides","volume":"140","author":"Fujii","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2013.05.008","article-title":"Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis","volume":"261","author":"Gomez","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0055","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.1002539","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis","volume":"186","author":"Gomez","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108327","article-title":"Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients","volume":"9","author":"Kordas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2014.12.001","article-title":"Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains","volume":"278","author":"Lazaridis","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijbiomac.2013.11.003","article-title":"Expression of human AChR extracellular domain mutants with improved characteristics","volume":"63","author":"Lazaridis","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0080","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.146.7.2245","article-title":"Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis","volume":"146","author":"Lennon","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0085","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1084\/jem.144.3.726","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1073\/pnas.75.2.769","article-title":"Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle","volume":"75","author":"Lindstrom","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0100","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","article-title":"Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors\u2014recommendations for methods and experimental designs","volume":"270","author":"Losen","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12031-009-9271-y","article-title":"Antigenic structure of the human muscle nicotinic acetylcholine receptor main immunogenic region","volume":"40","author":"Luo","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2004.04.010","article-title":"Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment","volume":"152","author":"Maiti","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IJGM.S88552","article-title":"Animal models of myasthenia gravis: utility and limitations","volume":"9","author":"Mantegazza","year":"2016","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(79)90823-7","article-title":"Long-term effects of repeated plasma exchange in myasthenia gravis","volume":"1","author":"Newsom-Davis","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0130","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04708","article-title":"Recent advances in cys-loop receptor structure and function","volume":"440","author":"Sine","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5114\/aoms.2013.36921","article-title":"Improved methodology to obtain large quantities of correctly folded recombinant N-terminal extracellular domain of the human muscle acetylcholine receptor for inducing experimental autoimmune myasthenia gravis in rats","volume":"10","author":"Sun","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0145","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.4238\/2015.July.14.4","article-title":"New method to induce myasthenia gravis models and the protective effect of soluble decay accelerating factors","volume":"14","author":"Sun","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-510X(88)90150-5","article-title":"Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor","volume":"85","author":"Takamori","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","article-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","volume":"163","author":"Tzartos","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0160","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0165","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-2478(94)90168-6","article-title":"Response to human acetylcholine receptor alpha 138\u2013199: determinant spreading initiates autoimmunity to self-antigen in rabbits","volume":"39","author":"Vincent","year":"1994","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mus.22273","article-title":"Ocular and generalized myasthenia gravis induced by human acetylcholine receptor gamma subunit immunization","volume":"45","author":"Wu","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0180","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.4049\/jimmunol.159.3.1570","article-title":"A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis","volume":"159","author":"Yoshikawa","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/eji.1830180410","article-title":"Cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica)","volume":"18","author":"Zhang","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0190","first-page":"538","article-title":"Identification of T-cell epitopes of autoantigens using recombinant proteins; studies on experimental autoimmune myasthenia gravis","volume":"71","author":"Zhang","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2008.06.020","article-title":"Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis","volume":"201\u2013202","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.12.011_bb0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbapap.2008.11.002","article-title":"Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties","volume":"1974","author":"Zouridakis","year":"2009","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816302338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816302338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:28:30Z","timestamp":1759048110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816302338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"alternative-id":["S0165572816302338"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.12.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}